Dr. Itakura's research focuses on developing methods for integrative analysis of multi-scale cancer data to improve patient outcomes. She uses machine learning and radiogenomic approaches to accelerate discoveries in cancer diagnostics and therapeutics.

The long-term goal of the research in Dr. Tharin's lab is the repair of damaged corticospinal circuitry.

Dr. Kebebew’s translational and clinical investigations have three main scientific goals: 1) to develop effective therapies for fatal, rare and neglected endocrine cancers, 2) to identify new methods, strategies and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognostication of endocrine cancers, and 3) to develop methods for precision treatment of endocrine tumors.

Dr. Tartakovsky's interests in biomedical modeling include blood flow, hemodynamics, microcirculation, intracellular and intercellular transport, cell biology, and bioinformatics.

The Nayak laboratory pursues basic and translational research into stem cell regeneration of the upper airway epithelium using animal models and human tissues obtained from sinus surgery.

The Frock lab uses genome-wide chromosomal translocation sequencing technologies to understand DNA double-strand break (DSB) repair. They apply these technologies to develop cancer diagnostics/treatments and to improve gene editing approaches.

The Loh Laboratory employs stem cells to reconstitute and understand human developmental biology, with the intention of generating pure populations of desired human tissue progenitors and creating a platform for stem cell-driven regenerative medicine.

Dr. Krane's current research interests involve the management of pain in children using intraspinal opioids, regional anesthetics, and novel analgesic agents; and cerebral and osmolar complications of diabetic ketoacidosis in children.

The Mercola laboratory is focused on developing new therapies for cardiovascular disease: their research combines in vitro disease models using cardiovascular cells generated from induced pluripotent stem cells with high throughput screening to define disease mechanisms, identify drug targets and develop drug leads.

Dr. So is interested in the diagnosis and treatment of neuromuscular diseases, including amyotrophic lateral sclerosis, neuropathies, myasthenia gravis, and electrophysiological characterization of these disorders.